Lakefront Biotherapeutics NV (LKFT)
Market price: $32.08
3 valuation methods
- P / E: $53.19 to $232.03 (midpoint $96.21)
- EV / Revenue: $64.14 to $191.81 (midpoint $101.97)
- EV / Gross Profit: $66.71 to $153.93 (midpoint $120.37)
How each method works
P / E: $53.19 to $232.03 (midpoint $96.21)
Values the stock at a peer multiple of its earnings per share — the most familiar gauge for steadily profitable companies.
- How it’s calculated
- We take the company's net earnings per share over the last twelve months and multiply them by the range of price-to-earnings (P/E) multiples its peers trade at.
- Why it fits this industry
- Large pharmaceutical companies convert patents into long, steady profit streams; the market's price for a dollar of those earnings is the sector's staple gauge.
- Reading this bar
- The bar is the per-share value range this method implies: a conservative low, a central estimate, and an optimistic high. If the current price sits below the bar, the market is pricing the shares below what this method's inputs suggest; if it sits above, the market is pricing them higher. No single bar is a verdict — methods disagree for good reasons, so read the whole field together. One unusually strong or weak year can swing a P/E — the inputs panel shows the earnings the bar is built on.
P / E = (9.67/17.49/42.17)× eps 5.50 ≈ 53.19/96.21/232.03 (per_share)
EV / Revenue: $64.14 to $191.81 (midpoint $101.97)
Values the whole business at a peer multiple of sales — used when earnings are thin, volatile, or not yet meaningful, so revenue is the most reliable yardstick.
- How it’s calculated
- We multiply the company's last-twelve-month revenue by the range of EV/Revenue multiples its peer group trades at, subtract net debt and any minority interests or preferred stock ranking ahead of common shareholders, and divide by shares outstanding for a per-share range.
- Why it fits this industry
- When profits are thin, volatile, or still to come, revenue is the most dependable figure a company reports — this method values the business on the scale of what it actually sells.
- Reading this bar
- The bar is the per-share value range this method implies: a conservative low, a central estimate, and an optimistic high. If the current price sits below the bar, the market is pricing the shares below what this method's inputs suggest; if it sits above, the market is pricing them higher. No single bar is a verdict — methods disagree for good reasons, so read the whole field together. A pound of revenue is worth more at a high margin than a low one, so the peer group here is narrowed to companies earning a similar margin wherever enough of them exist. Where too few do, the bar falls back to the wider group and is the bluntest of the multiples — weigh it alongside the earnings-based bars.
EV / Revenue = (3.29/5.27/9.98)× revenue 1,256,821,484.45 ≈ 4,131,377,138.03/6,624,145,957.59/12,544,289,664.99 (enterprise_value); enterprise_value -> per share: equity (4,226,496,913.03/6,719,265,732.59/12,639,409,439.99) / 65,897,071 shares [EV bridge: minus net debt -95,119,775.00]
EV / Gross Profit: $66.71 to $153.93 (midpoint $120.37)
Values the business at a peer multiple of gross profit — useful where reported operating costs vary a lot across peers but gross economics are comparable.
- How it’s calculated
- We take last-twelve-month gross profit (revenue minus the direct cost of the goods or services sold), multiply it by the peer range of EV/Gross-Profit multiples, subtract net debt and any minority interests or preferred stock ranking ahead of common shareholders, and divide by shares outstanding.
- Why it fits this industry
- Gross profit sits between revenue and operating earnings: it credits the margin a company's products earn while ignoring overhead and investment choices that legitimately differ across peers.
- Reading this bar
- The bar is the per-share value range this method implies: a conservative low, a central estimate, and an optimistic high. If the current price sits below the bar, the market is pricing the shares below what this method's inputs suggest; if it sits above, the market is pricing them higher. No single bar is a verdict — methods disagree for good reasons, so read the whole field together.
EV / Gross Profit = (3.52/6.41/8.21)× gross_profit 1,223,220,305.88 ≈ 4,300,968,952.95/7,836,833,630.10/10,048,491,194.11 (enterprise_value); enterprise_value -> per share: equity (4,396,088,727.95/7,931,953,405.10/10,143,610,969.11) / 65,897,071 shares [EV bridge: minus net debt -95,119,775.00]
4 methods not shown
- EV / EBITDA: ebitda unavailable — cannot form EV / EBITDA
- P / B: the market prices this company far outside its sector's P / B range (its own multiple is 0.56 vs a sector band of 2.76–9.03) — a sector-average bar would be misleading here, so it is withheld
- DCF (FCFF): DCF input(s) unavailable (da) — cannot build FCFF
- P / E — adjusted: adjusted_eps unavailable — cannot form P / E — adjusted